(Total Views: 469)
Posted On: 06/21/2021 11:37:39 AM
Post# of 22465
Interesting also when we take a look at pasacacapital.com then link to Innova!
https://pasacacapital.com/case-study/innova-medical-group/
What’s Next
Growing at an unprecedented rate, Innova continues to expand its operations, supplying rapid antigen test kits to major banking and event organizations, and will soon sell its product on the consumer market in many more territories including the United States. The company aims to supply test kits to those who normally wouldn’t have access to them and help governments and authorities distribute the tests to the local population.
As COVID-19 grows into an endemic, Innova continues to innovate with its rapid antigen test. The company is working on the next generation of Innova rapid antigen test with higher sensitivity and an anti-counterfeiting feature, while still keeping its products affordable.
Looking beyond the pandemic, Innova has multiple non-COVID related products on the horizon, ranging from stroke and cancer diagnostics to cardiovascular and pulmonary aid devices. With the help of Pasaca Capital, Innova has in record time grown into one of the preeminent market leaders in the medical field and has become a beacon of hope to those suffering from the pandemic and other illnesses.
The merger/acquisition is happening!
$5+
https://pasacacapital.com/case-study/innova-medical-group/
What’s Next
Growing at an unprecedented rate, Innova continues to expand its operations, supplying rapid antigen test kits to major banking and event organizations, and will soon sell its product on the consumer market in many more territories including the United States. The company aims to supply test kits to those who normally wouldn’t have access to them and help governments and authorities distribute the tests to the local population.
As COVID-19 grows into an endemic, Innova continues to innovate with its rapid antigen test. The company is working on the next generation of Innova rapid antigen test with higher sensitivity and an anti-counterfeiting feature, while still keeping its products affordable.
Looking beyond the pandemic, Innova has multiple non-COVID related products on the horizon, ranging from stroke and cancer diagnostics to cardiovascular and pulmonary aid devices. With the help of Pasaca Capital, Innova has in record time grown into one of the preeminent market leaders in the medical field and has become a beacon of hope to those suffering from the pandemic and other illnesses.
The merger/acquisition is happening!
$5+
(1)
(0)
